Updates on Tumor - Agnostic Treatment Approaches and Biomarker Testing

 

ASCO GI 2023 Conference Coverage
Avatar

ASCO GI 2023 ctDNA Informs Clinical Practice in Patients With Recurrent/Metastatic Gastroesophageal Cancers

By ASCO GI 2023 Conference Coverage FEATURING Rutika Mehta
By ASCO GI 2023 Conference Coverage FEATURING Rutika Mehta
499 views
January 31, 2023
0 Comments
Login to view comments. Click here to Login
Updates on Tumor - Agnostic Treatment Approaches and Biomarker Testing
11:09
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "A Phase 2 Basket Study of Tucatinib &…

Feat. Y. Nakamura
06:58
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "The Primary Endpoint Analysis of the Phas…

Feat. H. Akamatsu
04:14
ecancer

ASCO® 2023 Insights: "Phase 3 LUNAR Study - Tumor Treating Fiel…

Feat. T. Leal
25:35
Total Health

NGS and Liquid Biopsy: Overcoming Challenges in Widespread Testing

Feat. S. Kazmi
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
16:29
2023 Texas Lung Cancer Conference Coverage

How to Incorporate Liquid Biopsy for NSCLC in Practice

Feat. L. Raez
15:57
Rush University Medical Center

Precision Medicine in Pancreatic Cancer: Treatment to Screening

Feat. F. Bishehsari
20:57
Paul Hofman

Updates in Precision Approaches to the Molecular Diagnosis of NSCLC

14:11
Lorenzo Belluomini

Selpercatinib in RET Fusion-Positive mNSCLC: Achievements and Gray A…

01:01
Lorenzo Belluomini

Lecture Summary - Selpercatinib in RET Fusion-Positive mNSCLC: Achie…

40:27
MedNews Week

Advances in Matching Patients After NGS for Personalized Cancer Ther…

Feat. R. Kurzrock
10:16
Eric Singhi

Testing for Targetable Mutations in NSCLC: Tissue vs. Liquid Biopsy

43:20
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Biomarker-Targeted Therapies in GI Cancers

Feat. V. Subbiah
27:37
Total Health

Cancer Diagnostics in GI: Gene Panels, Liquid Biopsy, and Genetics

Feat. A. Magliocco
14:27
ecancer

Latest in Lung Cancer Genomic Testing

Feat. S. Popat
07:20
ASCO GI 2023 Conference Coverage

ASCO GI 2023 ctDNA Informs Clinical Practice in Patients With Recurr…

Feat. R. Mehta
58:12
Moffitt Cancer Center

RET Altered Thyroid Cancer

Feat. S. Agosto Salgado
54:49
Penn Medicine Abramson Cancer Center

Updates and Management of Medullary Thyroid Cancer: Genetic Testing …

Feat. V. Livolsi, K. Nathanson, L. L. Sun, R. Kelz, S. Mandel